Histocompatibility complex (HLA)

The major histocompatibility complex (MHC) is the cell surface proteins, which are vital for the acquired immune system to identify foreign molecules in vertebrates, which in turn concludes histocompatibility. The chief purpose of MHC molecules is to bind to peptide fragments resulting from pathogens and exhibit them on the cell surface for recognition by the suitable T-cells. A MHC molecule enables the interactions of leukocytes, which are also known as white blood cells (WBCs), these are immune cells, with other leukocytes or with body cells. The MHC defines compatibility of contributors for organ transplant, as well as one's vulnerability to an autoimmune disease via cross reacting immunization. In humans, the MHC is also titled as the human leukocyte antigen (HLA).

    Related Conference of Histocompatibility complex (HLA)

    August 29-30, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA
    August 31 - September 01, 2018

    International Conference and Expo on Dermatopathology and Skin Care

    Toronto, Canada
    September 17-18, 2018

    16th Annual Conference on Laboratory Medicine & Pathology

    Abu Dhabi, UAE
    September 17-18, 2018

    16th Asia Pacific Pathology Congress

    Tokyo, Japan
    October 15-16, 2018

    3rd International Conference on Internal Medicine & Hospital Medicine

    Ottawa, Ontario, Canada
    October 18-19, 2018

    European Pathology and Infectious Disease Conference

    Helsinki, Finland
    March 22-23, 2019 |

    World Birth Congress

    New York, USA
    (14 Forums, 2 Days, 1 Event)

    Histocompatibility complex (HLA) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in